1.Pontine toxoplasmosis in an immunocompromised Filipino male: A case report.
Michelangelo D. Liban ; Laurence Kristoffer J. Batino ; Debbie Co Liquete
Philippine Journal of Neurology 2022;25(1):24-27
A 36-year-old-male was admitted complaining of headache, right sided weakness and
numbness of upper and lower extremity, and multiple cranial nerve deficits. Cranial magnetic
resonance imaging revealed an abscess in the pontomesencephalic junction. Patient was then
diagnosed to have Human Immunodeficiency Virus with a CD 4 count of 32 cells/ uL, his CSF
assay was positive for Toxoplasmosis IgG and was managed as a case of probable brainstem
toxoplasmosis. Patient was treated with Co-Trimoxazole 800/160mg 2 tablets twice a day. Upon
discharge the patient clinically improved and was tolerating oral feeding. A repeat cranial
magnetic resonance imaging after 6 weeks of antibiotic treatment revealed a decrease of size in
the previous lesion. To our knowledge, there are no reported cases in the Philippines that shows
the documentation of CNS toxoplasmosis in the brainstem. In this paper, a case of CNS
toxoplasmosis in the pons of a newly diagnosed HIV patient is presented and how its course led
to a good outcome.
Toxoplasmosis
;
Immunocompromised Host
2.Hepatocellular Liver Function of Immunosuppressed Rats with Oral Candidiasis after Hyperbaric Oxygen Treatment: Alanine Transaminase and Aspartate Transaminase Levels
Agni Febrina Pargaputri ; Dwi Andriani
Archives of Orofacial Sciences 2021;16(SUPP 1):5-9
ABSTRACT
Hepatocellular utility is observed by measuring the hepatocellular enzymes. Changes in its serum
levels are related to liver dysfunction. Liver is one of the immunoprotective organs. Continuous use
of immunosuppressive drugs can cause oral candidiasis and give effects to liver function. Hyperbaric
oxygen treatment (HBOT), while reducing fungal infections, can also repair the liver function. The
aim of this study was to investigate the alanine transaminase (ALT) and aspartate transaminase (AST)
levels of immunosuppressed rats with oral candidiasis treated with hyperbaric oxygen. Twelve Wistar
rats were divided into three groups: K− (normal/ healthy), K+ (oral candidiasis immunosuppressed
rats), and P (oral candidiasis immunosuppressed rats treated hyperbaric oxygen). K+ and P groups were
immunosuppressed by giving dexamethasone 0.5 mg/day/rat orally for 14 days, added with tetracycline
1 mg/day/rat. HBOT was given in five days successively. Blood serum of rats in all groups were taken
to calculate the ALT and AST levels. ALT and AST levels in K+ showed higher value than K− and
P groups. The data were analysed with one-way ANOVA test and showed significant difference in
ALT levels (p < 0.05), while in AST levels there was no significant difference among the groups
(p > 0.05). This study showed that HBOT affected the ALT and AST levels of immunosuppressed rats
with oral candidiasis.
Carcinoma, Hepatocellular
;
Hyperbaric Oxygenation
;
Immunocompromised Host
;
Candidiasis, Oral--therapy
;
Alanine Transaminase
;
Aspartate Aminotransferases
3.Weathering the storm: COVID-19 infection in patients with hematological malignancies.
Lin-Qin WANG ; Elaine TAN SU YIN ; Guo-Qing WEI ; Yong-Xian HU ; Arnon NAGLER ; He HUANG
Journal of Zhejiang University. Science. B 2020;21(12):921-939
The coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Within a matter of months, this highly contagious novel virus has led to a global outbreak and is still spreading rapidly across continents. In patients with COVID-19, underlying chronic diseases and comorbidities are associated with dismal treatment outcomes. Owing to their immunosuppressive status, patients with hematological malignancies (HMs) are at an increased risk of infection and have a worse prognosis than patients without HMs. Accordingly, intensive attention should be paid to this cohort. In this review, we summarize and analyze specific clinical manifestations for patients with coexisting COVID-19 and HMs. Furthermore, we briefly describe customized management strategies and interventions for this susceptible cohort. This review is intended to guide clinical practice.
COVID-19/prevention & control*
;
Diagnosis, Differential
;
Disease Management
;
Hematologic Neoplasms/virology*
;
Hospitalization
;
Humans
;
Immunocompromised Host
;
Risk Factors
4.Updates in penile prosthesis infections.
Amanda R SWANTON ; Ricardo M MUNARRIZ ; Martin S GROSS
Asian Journal of Andrology 2020;22(1):28-33
Inflatable penile prostheses are an important tool in the treatment of medically refractory erectile dysfunction. One of the major complications associated with these prostheses is infections, which ultimately require device explanation and placement of a new device. Over the past several decades, significant work has been done to reduce infection rates and optimize treatment strategies to reduce patient morbidity. This article reviews the current state of knowledge surrounding penile prosthesis infections, with attention to the evidence for methods to prevent infection and best practices for device reimplantation.
Anti-Bacterial Agents/therapeutic use*
;
Anti-Infective Agents, Local/therapeutic use*
;
Antibiotic Prophylaxis/methods*
;
Bandages
;
Carrier State/drug therapy*
;
Chlorhexidine/therapeutic use*
;
Coated Materials, Biocompatible
;
Device Removal
;
Diabetes Mellitus/epidemiology*
;
Erectile Dysfunction/surgery*
;
Gram-Negative Bacterial Infections/therapy*
;
Hair Removal/methods*
;
Humans
;
Immunocompromised Host/immunology*
;
Male
;
Penile Implantation/methods*
;
Penile Prosthesis
;
Preoperative Care/methods*
;
Prosthesis-Related Infections/therapy*
;
Reoperation
;
Risk Factors
;
Spinal Cord Injuries/epidemiology*
;
Staphylococcal Infections/therapy*
;
Staphylococcus aureus
;
Staphylococcus epidermidis
;
Surgical Drapes
;
Surgical Instruments
;
Surgical Wound Infection/therapy*
5.Strongyloidiasis Presenting as Yellowish Nodules in Colonoscopy of an Immunocompetent Patient
Hannah RA ; Jun Won CHUNG ; Dong Hae CHUNG ; Jung Ho KIM ; Yoon Jae KIM ; Kyoung Oh KIM ; Kwang An KWON ; Dong Kyun PARK
Clinical Endoscopy 2019;52(1):80-82
Strongyloides stercoralis is endemic to tropical and subtropical regions, and infections are usually asymptomatic. However, immunocompromised patients, such as those receiving immunosuppressive therapy, high-dose steroids, or chemotherapy, can develop fatal hyperinfections. An 84-year-old man without any symptoms was diagnosed with strongyloidiasis during a regular screening colonoscopy. His medical history only involved a gastric endoscopic submucosal dissection for early gastric cancer 6 months previously. Few cases have been published about asymptomatic strongyloidiasis diagnosed in an immunocompetent host via endoscopic mucosal resection with characteristic colonoscopic findings. We report a case of colon-involved asymptomatic strongyloidiasis with specific colonic findings of yellowish-white nodules. This finding may be an important marker of S. stercoralis infection, which could prevent hyperinfections.
Aged, 80 and over
;
Colon
;
Colonoscopy
;
Drug Therapy
;
Humans
;
Immunocompromised Host
;
Mass Screening
;
Steroids
;
Stomach Neoplasms
;
Strongyloides stercoralis
;
Strongyloidiasis
6.A clinico-epidemiological multicenter study of herpes zoster in immunocompetent and immunocompromised hospitalized children
Ji Hyen HWANG ; Ki Hwan KIM ; Seung Beom HAN ; Hyun Hee KIM ; Jong Hyun KIM ; Soo Young LEE ; Ui Yoon CHOI ; Jin Han KANG
Clinical and Experimental Vaccine Research 2019;8(2):116-123
PURPOSE: There are limited population-based data regarding herpes zoster in children. Thus we conducted a multi-institutional epidemiological analysis of herpes zoster in children and comparative analysis according to their immune status. MATERIALS AND METHODS: The study included 126 children under the age of 18 years who were hospitalized for herpes zoster at 8 hospitals in South Korea, between July 2009 and June 2015. The subjects were divided into 2 groups according to their immune status, and medical records were reviewed. RESULTS: There were 61 cases (48.4%) in the immunocompetent group and 65 cases (51.6%) in the immunocompromised group. Median age was older in immunocompromised group (11.4 vs. 8.6) (p<0.001). The mean duration of hospitalization was longer in immunocompromised group (11.0 vs. 6.6) (p<0.001). Patients were treated with oral or intravenous antiviral agents. A total of 12 in immunocompetent group were cured only by oral acyclovir. No treatment failure was found in both groups. Six immunocompromised patients had postherpetic neuralgia and 1 case was in immunocompetent group. In immunocompetent children, herpes zoster was likely caused by early varicella infection. There was no increase in progression of severity in both groups due to appropriate treatment. CONCLUSION: Early initiation of therapy is necessary for those in immunocompromised conditions. And inactivated herpes zoster vaccination may be considered in immunocompromised adolescents in the future.
Acyclovir
;
Adolescent
;
Antiviral Agents
;
Chickenpox
;
Child
;
Child, Hospitalized
;
Herpes Zoster
;
Hospitalization
;
Humans
;
Immunocompromised Host
;
Korea
;
Medical Records
;
Neuralgia, Postherpetic
;
Treatment Failure
;
Vaccination
7.A Case of Infantile Fungal Urinary Tract Infection
Wonhee CHO ; Young Min JO ; Yun Kyo OH ; Ji Woo RIM ; Won Uk LEE ; Kyongeun CHOI ; Jeong Hee KO ; Yeon Jin JEON ; Yumi CHOI
Childhood Kidney Diseases 2019;23(2):121-123
Urinary tract infection is common in the pediatric population. The most common causative agents are bacteria, among which Escherichia coli is the most frequent uropathogen. Although fungal urinary tract infection is rare in the healthy pediatric population, it is relatively common among hospitalized patients. Fungus may be isolated from the urine of immunocompromised patients or that of patients with indwelling catheters. The most common cause of funguria is Candida albicans. Although more than 50% of Candida isolates belong to non-albicans Candida , the prevalence of non-albicans candiduria is increasing. Herein, we report a case of community-acquired candiduria in a 4-month-old immunocompetent male infant who had bilateral vesicoureteral reflux and was administered antibiotic prophylaxis. He was diagnosed with urinary tract infection caused by Candida lusitaniae and was managed with fluconazole.
Antibiotic Prophylaxis
;
Bacteria
;
Candida
;
Candida albicans
;
Catheters, Indwelling
;
Escherichia coli
;
Fluconazole
;
Fungi
;
Humans
;
Immunocompromised Host
;
Infant
;
Male
;
Prevalence
;
Urinary Tract Infections
;
Urinary Tract
;
Vesico-Ureteral Reflux
8.Eggerthella Lenta Bacteremia after Appendectomy in a Healthy Patient
Sara JEONG ; Hyun Young PARK ; In Taik HONG ; Jae Bin KANG ; Soo Youn MOON ; Ki Ho PARK ; Mi Suk LEE ; Jun Seong SON
Korean Journal of Medicine 2019;94(6):530-532
Eggerthella lenta (E. lenta) has been reported to cause bacteremia in patients with gastrointestinal tract disorders or malignancies and in immunocompromised patients. Cases of E. lenta have been increasing with the recent development of testing equipment. The mortality rate due to E. lenta bacteremia is high. The authors report a case of E. lenta bacteremia in an immunocompetent patient.
Appendectomy
;
Bacteremia
;
Gastrointestinal Tract
;
Humans
;
Immunocompromised Host
;
Mortality
9.Validation of Voriconazole Therapeutic Drug Monitoring in Lung Transplant Recipients Receiving Voriconazole alone for Treatment of Invasive Aspergillosis
Yu Jeong SON ; Kyung A LEE ; Ju Hee JO ; Jae Song KIM ; Eun Sun SON ; Moo Suk PARK
Korean Journal of Clinical Pharmacy 2019;29(2):89-100
BACKGROUND: Invasive aspergillosis (IA) is associated with high morbidity and mortality, particularly among immunocompromised patients, such as lung transplant recipients. Voriconazole, the first-line therapy for IA, shows a non-linear pharmacokinetic profile and has a narrow therapeutic range. Careful and appropriate administration is necessary, primarily because it is used for critically ill patients; however, the clinical usefulness of therapeutic drug monitoring (TDM) has not been sufficiently verified. Therefore, in this study, we validated the safety and efficacy of voriconazole TDM in lung transplant recipients receiving only voriconazole for IA treatment. METHODS: The electronic medical records of lung transplant recipients (≥19 years of age) administered only voriconazole for > 7 days for treatment of IA from June 1, 2013 to May 31, 2018 were analyzed retrospectively. RESULTS: Among the 54 patients, 27 each were allocated to TDM and non-TDM groups, respectively. There were no significant differences in patient characteristics between the two groups except for ICU-hospitalization status. Of the TDM group patients, 81.5% needed adjustment of voriconazole dosage because the levels were out of target range. Comparison of two groups showed that treatment response was higher throughout treatment and switching rates of second-line agents were significantly lower in the TDM group, but it was insufficient to confirm safety improvements through voriconazole TDM. CONCLUSION: Considering that the treatment response tended to be higher and the rates of switching to second-line antifungal agents were lower in the TDM group, voriconazole TDM may increase the therapeutic effect on IA in lung transplant patients.
Antifungal Agents
;
Aspergillosis
;
Critical Illness
;
Drug Monitoring
;
Electronic Health Records
;
Humans
;
Immunocompromised Host
;
Lung Transplantation
;
Lung
;
Mortality
;
Retrospective Studies
;
Transplant Recipients
;
Voriconazole
10.A Case of Septal Abscess and Sphenoid Sinusitis after Dental Implant
Jun LEE ; Su Jin KIM ; Myoung Su CHOI
Korean Journal of Otolaryngology - Head and Neck Surgery 2019;62(4):242-245
A nasal septal abscess results from the collection of purulent fluid between the cartilage of bony septum and overlying mucoperichondrium or mucoperiosteum. Unless early diagnosis and surgical treatment are performed, serious complications such as cavernous sinus thrombophlebitis, sepsis, and saddle nose may occur. We report a case of septal abscess and sphenoid sinusitis that occurred after dental implant. A 74-year-old female with diabetes and liver cirrhosis was referred to the hospital for management of rapidly aggravated perinasal pain, nasal obstruction, and headache. The patient had undergone dental implant in the right upper incisor area 6 days ago. A CT revealed septal abscess and bilateral sphenoid sinusitis. The patient was operated upon to drain septal abscess, and both sphenoid sinuses were opened widely.
Abscess
;
Aged
;
Cartilage
;
Cavernous Sinus Thrombosis
;
Dental Implants
;
Early Diagnosis
;
Female
;
Headache
;
Humans
;
Immunocompromised Host
;
Incisor
;
Liver Cirrhosis
;
Nasal Obstruction
;
Nasal Septum
;
Nose
;
Sepsis
;
Sphenoid Sinus
;
Sphenoid Sinusitis


Result Analysis
Print
Save
E-mail